A maintenance dose of atazanavir/ritonavir 200/100 mg once daily is effective in virologically suppressed HIV-1-infected patients

Massimiliano Lanzafame; Emanuela Lattuada; Fabio Rigo; Sandro Vento

doi:10.1097/QAI.0b013e3182928f10

A maintenance dose of atazanavir/ritonavir 200/100 mg once daily is effective in virologically suppressed HIV-1-infected patients

Massimiliano Lanzafame, Emanuela Lattuada, Fabio Rigo, Sandro Vento

Department of Medicine

Research output: Contribution to journal › Letter › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	e81-e82
Journal	Journal of Acquired Immune Deficiency Syndromes
Volume	63
Issue number	2
DOIs	https://doi.org/10.1097/QAI.0b013e3182928f10
Publication status	Published - Jun 1 2013

ASJC Scopus subject areas

Infectious Diseases
Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/QAI.0b013e3182928f10

Cite this

@article{02d86716eaec4d2cac3f53bf7afe140c,

title = "A maintenance dose of atazanavir/ritonavir 200/100 mg once daily is effective in virologically suppressed HIV-1-infected patients",

author = "Massimiliano Lanzafame and Emanuela Lattuada and Fabio Rigo and Sandro Vento",

year = "2013",

month = jun,

day = "1",

doi = "10.1097/QAI.0b013e3182928f10",

language = "English",

volume = "63",

pages = "e81--e82",

journal = "Journal of Acquired Immune Deficiency Syndromes",

issn = "1525-4135",

publisher = "Lippincott Williams and Wilkins",

number = "2",

}

TY - JOUR

T1 - A maintenance dose of atazanavir/ritonavir 200/100 mg once daily is effective in virologically suppressed HIV-1-infected patients

AU - Lanzafame, Massimiliano

AU - Lattuada, Emanuela

AU - Rigo, Fabio

AU - Vento, Sandro

PY - 2013/6/1

Y1 - 2013/6/1

UR - http://www.scopus.com/inward/record.url?scp=84879745373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879745373&partnerID=8YFLogxK

U2 - 10.1097/QAI.0b013e3182928f10

DO - 10.1097/QAI.0b013e3182928f10

M3 - Letter

C2 - 23666142

AN - SCOPUS:84879745373

SN - 1525-4135

VL - 63

SP - e81-e82

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

IS - 2

ER -

A maintenance dose of atazanavir/ritonavir 200/100 mg once daily is effective in virologically suppressed HIV-1-infected patients

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this